Exact Sciences Raises Net Proceeds of $57.8M in Public Offering | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences has raised $57.8 million in net proceeds from its public offering, the Madison, Wis.-based firm announced after the close of the market on Monday.

The company sold a total of 6,325,000 shares of its common stock at $9.75 per share. Jefferies and Co. and R.W. Baird were joint book-running managers in the offering, and William Blair & Co. and JMP Securities were co-managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.